The bill
ALERT Communities Act
HR. 1561, 119th Congress β read as touching Medical Devices.
Sponsored by
Rep. Crockett, Jasmine [D-TX-30]
ID: C001130
Follow the money
The bill
HR. 1561, 119th Congress β read as touching Medical Devices.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
23 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Forwarded by Subcommittee to Full Committee by Voice Vote.
June 24, 2026
π Current Status
Next: The bill moves to the floor for full chamber debate and voting.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Another bill, another opportunity for our esteemed lawmakers to pretend they care about the opioid crisis while actually just throwing more money at their pharmaceutical friends and padding their own resumes.
**Main Purpose & Objectives:** The ALERT Communities Act (HR 1561) claims to address the fentanyl and xylazine epidemics by authorizing research, training, and grant funding for test strips that can detect these substances. How noble. In reality, this bill is a Band-Aid on a bullet wound, designed to make politicians look like they're doing something while actually just perpetuating the same failed policies.
**Key Provisions & Changes to Existing Law:** The bill amends the Public Health Service Act to include training for first responders on using fentanyl and xylazine test strips. Oh, wow, I'm sure that'll solve everything. It also requires the Secretary of Health and Human Services to develop research and marketing frameworks for test strip technology because, clearly, what we need is more bureaucracy and red tape.
**Affected Parties & Stakeholders:** The usual suspects will benefit from this bill: pharmaceutical companies, medical device manufacturers, and politicians looking for a photo op. First responders might get some token training, but let's be real, they're already overwhelmed with the consequences of our failed drug policies. The actual victims of the opioid crisis? Just more empty promises.
**Potential Impact & Implications:** This bill will do what all bills like this do: create a temporary distraction from the real issues while funneling more money to special interests. It won't address the root causes of the opioid epidemic, such as overprescription and lack of access to treatment. Instead, it'll just throw more test strips at the problem, hoping that somehow, magically, people will stop overdosing.
In medical terms, this bill is like prescribing a patient with stage IV cancer a few aspirin and calling it a day. It's a pathetic attempt to treat the symptoms while ignoring the underlying disease. But hey, at least our politicians can say they "did something" about the opioid crisis... until the next election cycle, when they'll need to pretend to care again.
Diagnosis: Terminal Stupidity Syndrome (TSS), characterized by an inability to address complex problems with meaningful solutions, instead opting for superficial fixes that benefit only those in power. Prognosis: Poor.
Rep. Crockett, Jasmine [D-TX-30]
Congress 119 β’ 2024 Election Cycle
No PAC contributions found
No committee contributions found
This bill has 1 cosponsors. Below are their top campaign contributors.
ID: G000589
Top Contributors
10
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 59 nodes and 26 connections (60 secondary connections hidden)
Total contributions: $95,600
Showing top 20 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 2 helped, 3 harmed.
Section 3 promotes the development and evaluation of test strip technology, potentially benefiting medical device manufacturers that produce diagnostic tools like these test strips.
Section 3 implies increased regulation on test strip technology for detecting fentanyl and other substances, which may impact pharmaceutical companies involved in opioid manufacturing or related fields.
The research and development of new test strip technologies (Section 3) could provide opportunities for biotech firms involved in diagnostic technologies or substance abuse treatment research.
By potentially reducing overdose cases through early detection (Section 2 and Section 4), hospitals might see a decrease in emergency admissions related to overdoses, affecting their revenue.
The overall aim to reduce overdose deaths and increase engagement in substance use disorder treatment (Section 4) could lead to reduced healthcare costs for insurers, but the direct impact is less clear than on other industries.
For each industry this bill affects, here's what the sponsor (Rep. Crockett, Jasmine [D-TX-30])received from donors associated with that industry during the 2022βpresent cycles. Donations are not proof of intent β they are a record of who funds the people writing the law.
To make revisions in title 51, United States Code, as necessary to keep the title current, and to make technical amendments to improve the United States Code.
119/hr/5174
Honoring the heroic military service, sacrifices, and contributions of veterans from the great State of Texas, and for other purposes.
119/hres/863